1,771
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

PepO is a target of the two-component systems VicRK and CovR required for systemic virulence of Streptococcus mutans

, ORCID Icon, ORCID Icon, ORCID Icon, , & show all
Pages 521-536 | Received 13 Jan 2020, Accepted 29 Mar 2020, Published online: 19 May 2020

References

  • Bowen WH, Burne RA, Wu H, et al. The virulence of Streptococcus mutans and the ability to form biofilms. Trends Microbiol. 2019;26:229–242.
  • Krzyściak W, Jurczak A, Kościelniak D, et al. The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis. 2014;33:499–515.
  • Lemos JA, Palmer SR, Zeng L, et al. The biology of Streptococcus mutans. Microbiol Spectr. 2019;7:1–26.
  • Nakano K, Nemoto H, Nomura R, et al. Serotype distribution of Streptococcus mutans a pathogen of dental caries in cardiovascular specimens from Japanese patients. J Med Microbiol. 2007;56:551–556.
  • Nakano K, Nomura R, Matsumoto M, et al. Roles of oral bacteria in cardiovascular diseases - from molecular mechanisms to clinical cases: cell-surface structures of novel serotype k Streptococcus mutans strains and their correlation to virulence. J Pharmacol Sci. 2010;113:120–125.
  • Nakano K, Nomura R, Ooshima T. Streptococcus mutans and cardiovascular diseases. Jpn Dent Sci Rev Internet. 2008;44:29–37.
  • Fernandes CP, Oliveira FAF, Silva PGDB, et al. Molecular analysis of oral bacteria in dental biofilm and atherosclerotic plaques of patients with vascular disease. Int J Cardiol. 2014;174:710–712.
  • Kesavalu L, Lucas AR, Verma RK, et al. Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice. J Dent Res. 2012;91:255–260.
  • Momeni SS, Ghazal T, Grenett H, et al. Streptococcus mutans serotypes and collagen-binding proteins Cnm/Cbm in children with caries analysed by PCR. Mol Oral Microbiol. 2019;34:64–73.
  • Nakano K, Inaba H, Nomura R, et al. Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin Microbiol. 2006;44:3313–3317.
  • Nakano K, Ooshima T. Serotype classification of Streptococcus mutans and its detection outside the oral cavity. Future Microbiol Internet. 2009;4:891–902.
  • Nomura R, Nakano K, Naka S, et al. Identification and characterization of a collagen-binding protein, Cbm, in Streptococcus mutans. Mol Oral Microbiol. 2012;27:308–323.
  • Avilés-Reyes A, Miller JH, Lemos JA, et al. Collagen-binding proteins of Streptococcus mutans and related streptococci. Mol Oral Microbiol. 2017;32:89–106.
  • Otsugu M, Nomura R, Matayoshi S, et al. Contribution of Streptococcus mutans strains with collagen binding proteins in the presence of serum to the pathogenesis of infective endocarditis. Infect Immun. 2017;85:1–17.
  • Abranches J, Miller JH, Martinez AR, et al. The collagen-binding protein Cnm is required for Streptococcus mutans adherence to and intracellular invasion of human coronary artery endothelial cells. Infect Immun. 2011;79:2277–2284.
  • Misaki T, Naka S, Hatakeyama R, et al. Presence of Streptococcus mutans strains harbouring the cnm gene correlates with dental caries status and IgA nephropathy conditions. Sci Rep. 2016;6:1–9.
  • Nakano K, Hokamura K, Taniguchi N, et al. The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun. 2011;2:485.
  • Nakano K, Lapirattanakul J, Nomura R, et al. Streptococcus mutans clonal variation revealed by multilocus sequence typing. J Clin Microbiol. 2007;45:2616–2625.
  • Avilés-Reyes A, Miller JH, Simpson-Haidaris PJ, et al. Cnm is a major virulence factor of invasive Streptococcus mutans and part of a conserved three-gene locus. Mol Oral Microbiol. 2014;29:11–23.
  • Kang M, Ko YP, Liang X, et al. Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway. J Biol Chem. 2013;288:20520–20531.
  • Ermert D, Blom AM. C4b-binding protein: the good, the bad and the deadly. novel functions of an old friend. Immunol Lett Internet. 2016;169:82–92.
  • Jarva H, Jokiranta TS, Würzner R, et al. Complement resistance mechanisms of streptococci. Mol Immunol. 2003;40:95–107.
  • Alves LA, De Carli TR, Chu ENH, et al. Oral streptococci show diversity in resistance to complement immunity. J Med Microbiol. 2019;68:600–608.
  • Alves LA, Harth-Chu EN, Palma TH, et al. The two-component system VicRK regulates functions associated with Streptococcus mutans resistance to complement immunity. Mol Oral Microbiol. 2017;32:419–431.
  • Alves LA, Nomura R, Mariano FS, et al. CovR regulates Streptococcus mutans susceptibility to complement immunity and survival in blood. Infect Immun. 2016;84:3206–3219.
  • Mattos-Graner RO, Duncan MJ. Two-component signal transduction systems in oral bacteria. J Oral Microbiol Internet. 2017;9:1400858.
  • Stipp RN, Boisvert H, Smith DJ, et al. CovR and VicRK regulate cell surface biogenesis genes required for biofilm formation in Streptococcus mutans. PLoS One. 2013;8:e58271.
  • Alves LA, Ganguly T, Mattos-Graner RO, et al. CovR and VicRKX regulate transcription of the collagen binding protein Cnm of Streptococcus mutans. J Bacteriol. 2018;200:pii: e00141-18.
  • Agarwal V, Kuchipudi A, Fulde M, et al. Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen-and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells. J Biol Chem. 2013;288:6849–6863.
  • Liu F, Li J, Yan K, et al. Binding of fibronectin to SsPepO facilitates the development of Streptococcus suis meningitis. J Infect Dis. 2018;217:973–982.
  • Pavlova SI, Wilkening RV, Federle MJ, et al. Streptococcus endopeptidases promote HPV infection in vitro. Microbiologyopen. 2019;8:1–14.
  • Agarwal V, Sroka M, Fulde M, et al. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence. J Biol Chem. 2014;289:15833–15844.
  • Honda-Ogawa M, Sumitomo T, Mori Y, et al. Streptococcus pyogenes endopeptidase O contributes to evasion from complement-mediated bacteriolysis via binding to human complement factor C1q. J Biol Chem. 2017;292:4244–4254.
  • Wilkening RV, Chang JC, Federle MJ. PepO, a CovRS-controlled endopeptidase, disrupts Streptococcus pyogenes quorum sensing. Mol Microbiol. 2016;99:71–87.
  • Mattos-Graner RO, Smith DJ, King WF, et al. Water-insoluble glucan synthesis by mutans streptococcal strains correlates with caries incidence in 12- to 30-month-old children. J Dent Res. 2000;79:1371–1377.
  • Negrini TC, Duque C, Vizoto NL, et al. Influence of VicRK and CovR on the interactions of Streptococcus mutans with phagocytes. Oral Dis. 2012;18:485–493.
  • Duque C, Stipp RN, Wang B, et al. Downregulation of GbpB, a component of the VicRK regulon, affects biofilm formation and cell surface characteristics of Streptococcus mutans. Infect Immun. 2011;79:786–796.
  • Biswas I, Drake L, Biswas S. Regulation of gbpC expression in Streptococcus mutans. J Bacteriol. 2007;189:6521–6531.
  • Macrina FL, Tobian JA, Jones KR, et al. A cloning vector able to replicate in Escherichia coli and Streptococcus sanguis. Gene. 1982;19:345–353.
  • Kim JN, Stanhope MJ, Burne RA. Core-gene-encoded peptide regulating virulence-associated traits in Streptococcus mutans. J Bacteriol. 2013;195:2912–2920.
  • Jung CJ, Zheng QH, Shieh YH, et al. Streptococcus mutans autolysin AtlA is a fibronectin-binding protein and contributes to bacterial survival in the bloodstream and virulence for infective endocarditis. Mol Microbiol. 2009;74:888–902.
  • Domenech M, Ramos-Sevillano E, García E, et al. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect Immun. 2013;81:2606–2615.
  • Potempa M, Potempa J, Okroj M, et al. Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J Immunol Internet. 2008;181:5537–5544.
  • Stipp RN, Gonçalves RB, Höfling JF, et al. Transcriptional analysis of gtfB, gtfC, and gbpB and their putative response regulators in several isolates of Streptococcus mutans. Oral Microbiol Immunol Internet. 2008;23:466–473.
  • Mattos-Graner RO, Jin S, King WF, et al. Cloning of the Streptococcus mutans gene encoding glucan binding protein B and analysis of genetic diversity and protein production in clinical isolates. Infect Immun. 2001;69:6931–6941.
  • Ricklin D, Reis ES, Mastellos DC, et al. Complement component C3 – the “swiss army knife” of innate immunity and host defense. Immunol Rev. 2016;274:33–58.
  • Senadheera DB, Cordova M, Ayala EA, et al. Regulation of bacteriocin production and cell death by the vicrk signaling system in Streptococcus mutans. J Bacteriol. 2012;194:1307–1316.
  • Durbeej M. Laminins. Cell Tissue Res. 2010;339:259–268.
  • van Lookeren Campagne M, Verschoor A. Pathogen clearance and immune adherence “revisited”: immuno-regulatory roles for CRIg. Semin Immunol. 2018;37:4–11.
  • Reis ES, Mastellos DC, Hajishengallis G, et al. New insights into the immune functions of complement. Nat Rev Immunol. 2019;19:503–516.
  • Avilés-Reyes A, Miller JH, Simpson-Haidaris PJ, et al. Modification of Streptococcus mutans Cnm by PgfS contributes to adhesion, endothelial cell invasion, and virulence. J Bacteriol. 2014;196:2789–2797.
  • Tsai CJY, Loh JMS, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence Internet. 2016;7:214–229.
  • Graham MR, Smoot LM, Migliaccio CAL, et al. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A. 2002;99:13855–13860.
  • Sumby P, Whitney AR, Graviss EA, et al. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2006;2: 0041–9.
  • Engleberg NC, Heath A, Miller A, et al. Spontaneous mutations in the CsrRS two‐component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis. 2001;183:1043–1054.
  • Dmitriev A, Mohapatra SS, Chong P, et al. CovR-controlled global regulation of gene expression in Streptococcus mutans. PLoS One. 2011;6:e20127.
  • Brouwer S, Cork AJ, Ong CLY, et al. Endopeptidase PepO regulates the SpeB cysteine protease and is essential for the virulence of invasive M1T1 Streptococcus pyogenes. J Bacteriol. 2018;200:1–13.
  • Underhill SAM, Shields RC, Hagen SJ. Carbohydrate and PepO control bimodality in competence development by Streptococcus mutans. Mol Microbiol. 2019;112:1388–1402.
  • Dubrac S, Bisicchia P, Devine KM, et al. A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol Microbiol. 2008;70:1307–1322.
  • Fukui A, Yuasa-Nakagawa T, Murakami Y, et al. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis. J Biochem. 2002;132:719–728.
  • Blom AM, Villoutreix BO, Dahlbäck B. Functions of human complement inhibitor C4b-binding protein in relation to its structure. Arch Immunol Ther Exp (Warsz). 2004;52:83–95.
  • Blom AM, Hallström T, Riesbeck K. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol. 2009;46:2808–2817.
  • Cole WG, Chan D, Hickey AJ, et al. Collagen composition of normal and myxomatous human mitral heart valves. Biochem J. 1984;219:451–460.
  • Carlsson F, Sandin C, Lindahl G. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol. 2005;56:28–39.
  • Nomura R, Otsugu M, Naka S, et al. Contribution of the interaction of Streptococcus mutans serotype k strains with fibrinogen to the pathogenicity of infective endocarditis. Infect Immun. 2014;82:5223–5234.
  • Reichhardt MP, Meri S. Intracellular complement activation—an alarm raising mechanism? Semin Immunol. 2018;38:54–62.
  • Barthel D, Schindler S, Zipfel PF. Plasminogen is a complement inhibitor. J Biol Chem. 2012;287:18831–18842.